Summary:
Phase 3 Study A randomized, double blinded, parallel arm study of the efficacy and safety of investigational Dulaglutide doses when added to Metformin in patients with Type 2 diabetetes.
Qualified Participants Must:
• Have a diagnosis of Type 2 diabetes for longer than 6 months
•
HgA1c=7.5 - 11
•
Be taking Metformin 1500mg or higher or documentation that they tried that dosage level but unable to tolerate it
Qualified Participants May Receive:
Study drug and all related materials.
Compensation for time and travel